{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:35:15Z","timestamp":1773268515252,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100005002","name":"California Department of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5NU58DP003862\u201004\/DP003862"],"award-info":[{"award-number":["5NU58DP003862\u201004\/DP003862"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","award":["HHSN261201000035C"],"award-info":[{"award-number":["HHSN261201000035C"]}],"id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001808","name":"Public Health Institute","doi-asserted-by":"publisher","award":["HHSN261201000034C"],"award-info":[{"award-number":["HHSN261201000034C"]}],"id":[{"id":"10.13039\/100001808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>This population\u2010based study considered the influence of rituximab on the survival of children (0\u201319\u00a0years), adolescents, and young adults (AYAs, 20\u201339 years) with diffuse large B\u2010cell lymphoma (DLBCL), including patients with human immunodeficiency virus (HIV) infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data on 642 children and AYAs diagnosed with DLBCL during 2001\u20132014 were obtained from the Greater Bay Area Cancer Registry in California. Facility\u2010level reports provided treatment details. The Kaplan\u2013Meier method estimated survival and Cox regression models examined the association between survival and rituximab use, adjusting for sociodemographic and clinical factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Rituximab use increased from 2001\u20132007 to 2008\u20132014 among children (from 32% to 48%), AYAs (from 68% to 84%), and HIV patients (from 57% to 67%). Five\u2010year survival was higher among children (91%) than AYAs (82%). On multivariable analysis, the hazard of death was 44% lower among rituximab recipients, and higher among uninsured patients, those with HIV, and those with advanced stage at diagnosis. HIV patients who received rituximab were 60% less likely to die than nonrecipients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study suggests a benefit of rituximab on the treatment of AYAs and HIV patients with DLBCL. The worse survival observed among HIV\u2010positive and uninsured patients is of concern and calls for further investigation. Careful consideration should be given on whether to recommend rituximab more often on the front\u2010line treatment of children and HIV\u2010positive patients with DLBCL.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.27559","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T09:29:28Z","timestamp":1543915768000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Survival after diffuse large B\u2010cell lymphoma among children, adolescents, and young adults in California, 2001\u20132014: A population\u2010based study"],"prefix":"10.1002","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1644-0313","authenticated-orcid":false,"given":"R.","family":"Abrah\u00e3o","sequence":"first","affiliation":[{"name":"Greater Bay Area Cancer Registry Cancer Prevention Institute of California  Fremont California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Department of Oncology and Global Pediatric Medicine Division of Leukemia and Lymphoma St. Jude Children's Research Hospital  Memphis Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.Y.","family":"Lichtensztajn","sequence":"additional","affiliation":[{"name":"Greater Bay Area Cancer Registry Cancer Prevention Institute of California  Fremont California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Center of Oncology Hematology Outcomes Research and Training University of California Davis School of Medicine  Sacramento California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.H.M.","family":"Keegan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Center of Oncology Hematology Outcomes Research and Training University of California Davis School of Medicine  Sacramento California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-33679-4_4"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-577189"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14860"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.522"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29869"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011240019516"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.10507"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-373738"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0595"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-231613"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253039"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-498964"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.7338"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4213"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-388470"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-297879"},{"key":"e_1_2_10_18_1","volume-title":"Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975\u20132000","author":"Bleyer A","year":"2006"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/824691"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0011"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23060"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.7817"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-517110"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/jayao.2014.0037"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.06.005"}],"updated-by":[{"DOI":"10.1002\/pbc.27768","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000}}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.27559","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.27559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:12:11Z","timestamp":1694715131000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.27559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1002\/pbc.27559"],"URL":"https:\/\/doi.org\/10.1002\/pbc.27559","archive":["Portico"],"relation":{"erratum":[{"id-type":"doi","id":"10.1002\/pbc.27768","asserted-by":"object"}]},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"2018-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e27559"}}